Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:PPHM
Delisted

Peregrine Pharmaceuticals Inc. Fund Price (Quote)

$4.22
+0 (+0%)
At Close: Jan 22, 2018

Range Low Price High Price Comment
30 days $3.86 $4.40 Monday, 22nd Jan 2018 PPHM stock ended at $4.22. During the day the stock fluctuated 0% from a day low at $4.22 to a day high of $4.22.
90 days $3.74 $5.48
52 weeks $1.97 $5.78

Historical Peregrine Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jan 28, 2016 $7.14 $7.28 $7.00 $7.07 112 614
Jan 27, 2016 $7.35 $7.63 $7.07 $7.07 94 057
Jan 26, 2016 $7.28 $7.49 $7.00 $7.42 116 886
Jan 25, 2016 $7.14 $7.49 $7.14 $7.21 106 671
Jan 22, 2016 $6.79 $7.35 $6.65 $7.14 153 629
Jan 21, 2016 $6.72 $6.86 $6.44 $6.58 113 571
Jan 20, 2016 $6.30 $6.72 $6.02 $6.65 148 886
Jan 19, 2016 $7.07 $7.07 $6.23 $6.51 234 429
Jan 15, 2016 $7.07 $7.21 $6.72 $7.00 207 343
Jan 14, 2016 $7.21 $7.35 $6.72 $7.14 177 186
Jan 13, 2016 $7.70 $7.70 $7.00 $7.07 201 371
Jan 12, 2016 $7.49 $7.70 $7.14 $7.42 218 814
Jan 11, 2016 $7.49 $7.77 $7.28 $7.49 226 114
Jan 08, 2016 $7.84 $7.98 $7.49 $7.49 129 243
Jan 07, 2016 $7.84 $7.84 $7.56 $7.63 169 029
Jan 06, 2016 $8.05 $8.19 $7.84 $7.91 129 700
Jan 05, 2016 $8.05 $8.26 $7.98 $8.12 107 871
Click to get the best stock tips daily for free!

About Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It’s lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In ... PPHM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT